Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, and High-Income Countries: A Systematic Review

被引：1

作者：

Purba, Abdul Khairul Rizki ^{[1
,2
,3
]}

Rosyid, Alfian Nur ^{[4
]}

Handayani, Samsriyaningsih ^{[5
]}

Rachman, Brian Eka ^{[6
]}

Romdhoni, Achmad Chusnu ^{[7
]}

Farabi, Makhyan Jibril Al ^{[8
]}

Wahyuhadi, Joni ^{[9
]}

Prananingtias, Rosita ^{[10
]}

Rahayu, Ainun Nitsa ^{[11
]}

Alkaff, Firas Farisi ^{[1
,12
]}

Azmi, Yufi Aulia ^{[13
,14
]}

Prasetyo, Sabarinah ^{[15
]}

Nadjib, Mardiati ^{[16
]}

Gutjahr, Lina Patricia ^{[17
]}

Humaidy, Raudia Faridah ^{[5
]}

机构：

[1] Univ Airlangga, Fac Med, Dept Anat Histol & Pharmacol, Div Pharmacol & Therapy, Surabaya, E Java, Indonesia

[2] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands

[3] Univ Airlangga, Fac Med, Med Educ Master Program, Surabaya, W Java, Indonesia

[4] Univ Airlangga, Fac Med, Dept Pulmonol & Resp Med, Surabaya, E Java, Indonesia

[5] Univ Airlangga, Fac Med, Dept Publ Hlth & Prevent Med, Surabaya, E Java, Indonesia

[6] Univ Airlangga, Fac Med, Dept Internal Med, Surabaya, E Java, Indonesia

[7] Univ Airlangga, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Surabaya, E Java, Indonesia

[8] Univ Airlangga, Soetomo Gen Hosp, Dept Cardiol & Vasc Med, Surabaya, E Java, Indonesia

[9] Univ Airlangga, Fac Med, Dept Neurosurg, Surabaya, E Java, Indonesia

[10] Univ Airlangga Hosp, Dept Med Record, Surabaya, E Java, Indonesia

[11] Univ Airlangga, Fac Med, Surabaya, E Java, Indonesia

[12] Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands

[13] Univ Airlangga, Dr Soetomo Gen Acad Hosp, Fac Med, Dept Urol, Surabaya, E Java, Indonesia

[14] Univ Groningen, Univ Med Ctr Groningen, Dept Dept Hlth Sci, Groningen, Netherlands

[15] Univ Indonesia, Fac Publ Hlth, Dept Biostat & Populat Studies, Depok, W Java, Indonesia

[16] Univ Indonesia, Fac Publ Hlth, Dept Hlth Adm & Policy, Depok, West Java, Indonesia

[17] Saarland Univ, Fac Med, Saarbrucken, Germany

来源：

MEDICAL SCIENCE MONITOR | 2024年 / 30卷

关键词：

Cost of Illness; Epidemiology; Mass Screening; SARS-CoV-2; Mortality; HEALTH-CARE; COST-EFFECTIVENESS;

D O I：

10.12659/MSM.943863

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Background: Economic evaluation of the testing strategies to control transmission and monitor the severity of COVID-19 after the pandemic is essential. This study aimed to review the economic evaluation of COVID-19 tests and to construct a model with outcomes in terms of cost and test acceptability for surveillance in the post-pandemic period in low-income, middle-income, and high-income countries. Material/Methods: We performed the systematic review following PRISMA guidelines through MEDLINE and EMBASE databases. We included the relevant studies that reported the economic evaluation of COVID-19 tests for surveillance. Also, we input current probability, sensitivity, and specificity for COVID-19 surveillance in the post-pandemic period. Results: A total of 104 articles met the eligibility criteria, and 8 articles were reviewed and assessed for quality. The specificity and sensitivity of COVID-19 screening tests were reported as 80% to 90% and 40% to 90%, respectively. The target population presented a mortality rate between 0.2% and 19.2% in the post -pandemic period. The implementation model of COVID-19 screening tests for surveillance with a cost mean for molecular and antigen tests was US$ 46.64 (min -max US $0.25-$105.39) and US $6.15 (min -max US $2-$10), respectively. Conclusions: For the allocation budget for the COVID-19 surveillance test, it is essential to consider the incidence and mortality of the post -pandemic period in low-income, middle -income, and high -income countries. A robust method to evaluate outcomes is needed to prevent increasing COVID-19 incidents earlier.

引用

页数：10

共 46 条

[1] Limitations of COVID-19 testing and case data for evidence-informed health policy and practice [J].